clenziderm m.d. system

Product NDC: 62032-613
11-digit product format: 620320613
Labeler code: 62032
Product ID: 62032-613_bab0a250-f922-44f7-bd9e-517ebeb25fa7
Type: HUMAN OTC DRUG
Nonproprietary name: SALICYLIC ACID AND BENZOYL PEROXIDE
Dosage form: KIT
Labeler: Obagi Cosmeceuticals LLC
Application: M006
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2012-01-01
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	62032-613	62032-613-01	D	Discontinued by firm		2026-10-12
excluded package	package	62032-613	62032-613-15	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 34 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-613-15	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-613-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-613-15	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-613-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-613-15	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-613-01	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-613-15	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-613-01	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-613-09	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-613-01	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-613-15	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-613-09	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-613-01	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-613-15	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-613-09	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-613-01	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-613-15	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-613-09	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-613-01	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-613-15	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-613-09	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-613-01	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-613-15	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-613-01	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-613-15	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-613-01	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-613-15	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-613-01	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-613-15	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: clenziderm m.d. system
Brand name suffix: acne therapeutic system
Listing expiration: 2026-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 7 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
106309	Internal RxNorm lookup
251577	Internal RxNorm lookup
562600	Internal RxNorm lookup
1235205	Internal RxNorm lookup
1235208	Internal RxNorm lookup
1236624	Internal RxNorm lookup
2191891	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7710e51a-dd3a-4f44-8c97-c089c6817cb0	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d9d61457-6a5a-41fc-b418-e5479a2904b7	Product name	2	20230303
32012d5c-25ac-49c7-9d4c-1313177fff7c	Product name	1	20230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06e	Product name	1	20220128
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
3f45980c-c196-47e5-0e5e-48b7c57327c5	Product name	5	20200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
62032-613-01	2025-03-19	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-09	2025-03-19	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-15	2025-03-19	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-01	2025-01-30	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-09	2025-01-30	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM
62032-613-15	2025-01-30	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-610-11	clenziderm m.d. systemacne therapeutic system	118 mL in 1 BOTTLE, PLASTIC	LIQUID	118 mL	20 mg in 1mL	3
62032-611-01	clenziderm m.d. systemacne therapeutic system	47 mL in 1 BOTTLE, PLASTIC	LOTION	47 mL	50 mg in 1mL	3
62032-612-04	clenziderm m.d. systemacne therapeutic system	148 mL in 1 BOTTLE, PLASTIC	LIQUID	148 mL	20 mg in 1mL	3
62032-613-01	clenziderm m.d. systemacne therapeutic system	1 in 1 CARTON	KIT	1		3
62032-613-09	clenziderm m.d. systemacne therapeutic system	1 in 1 CARTON	KIT	1		3
62032-613-15	clenziderm m.d. systemacne therapeutic system	1 in 1 CARTON	KIT	1		3
62032-613-15	clenziderm m.d. systemacne therapeutic system	1 in 1 BAG	KIT	1		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-613	CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OBAGI COSMECEUTICALS LLC]	3	Current NDC, Legacy NDC, 7 package rows	20250322_7710e51a-dd3a-4f44-8c97-c089c6817cb0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 38 of 55 · 1,088 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TREAT SO DEEP ACNE-FIGHTING TREATMENT	SALICYLIC ACID	ASPIRE BRANDS INC	d18b4f15-9ea1-4d76-a1e3-a0be1c5bb58a	2024-12-06	Warnings	Exact identifier application number: M006
Oxy Maximum Strength Rapid Spot Treatment	OXY MAXIMUM STRENGTH RAPID SPOT TREATMENT	The Mentholatum Company	28886273-a71a-46ea-e063-6394a90ac11d	2024-12-05	Warnings	Exact identifier application number: M006
Dermaclear Spot Treatment	BENZOYL PEROXIDE	Allure Labs Inc	45a93c47-552f-4660-a37c-7a8cceac2d8e	2024-12-05	Warnings	Exact identifier application number: M006
DermaClear Pads	SALICYLIC ACID	Allure Labs	0c6624fd-88f9-402c-8ac2-bc278242b484	2024-12-05	Warnings	Exact identifier application number: M006
DermaClear BHA Spot Treatment	SALICYLIC ACID	Allure Labs	b629cb05-548e-4d60-e053-2a95a90aeefb	2024-12-05	Warnings	Exact identifier application number: M006
Acne Treatment Maximum Strength	SALICYLIC ACID	Young Living Essential Oils, LC	756a52ff-161d-4b6e-933b-49bce885d998	2024-12-04	Warnings	Exact identifier application number: M006
DermaClear Serum	SALICYLIC ACID	Allure Labs Inc	487a7d1c-0f98-4d36-bfe9-c12bcda8d0b3	2024-12-04	Warnings	Exact identifier application number: M006
Dermaclear Mask	SALICYLIC ACID	Allure Labs Inc,	9429f477-a916-49c9-bf04-1cf591af5c7f	2024-12-04	Warnings	Exact identifier application number: M006
Clear System Clarifying Gel Cleanser	SALICYLIC ACID	Bentley Laboratories, LLC	08248e40-aa71-4dfb-8a75-af8886ccb976	2024-12-04	Warnings	Exact identifier application number: M006
DermaClear BHA Cleanser	SALICYLIC ACID	Allure Labs Inc	bfeced33-a630-4f1d-9ecf-33450bd26ae9	2024-12-03	Warnings	Exact identifier application number: M006
PCA SKIN Intensive Clarity Treatment	SALICYLIC ACID	CP Skin Health Group, Inc.	7bd6edc0-941e-492d-8b3c-4e8b3425f929	2024-12-03	Warnings	Exact identifier application number: M006
PCA SKIN BPO Cleanser	BENZOYL PEROXIDE	CP Skin Health Group, Inc.	eb55cc26-cf47-4e9e-b7a8-23ef82aecce2	2024-12-03	Warnings	Exact identifier application number: M006
PCA SKIN Acne	BENZOYL PEROZIDE	CP Skin Health Group, Inc.	257bd9dd-93f9-4996-8478-8198be3ef683	2024-12-03	Warnings	Exact identifier application number: M006
PCA Gel	SALICYLIC ACID	CP Skin Health Group, Inc	396b4675-451f-48b2-b139-19508434e0fe	2024-12-03	Warnings	Exact identifier application number: M006
CliniCalm	HYDROCORTISONE	CP Skin Health Group, Inc.	febcf7e8-668c-a5c9-e053-6394a90aec39	2024-12-03	Warnings	Exact identifier application number: M006
Alumier MD Acne Clarifying Cleanser	SALICYLIC ACID	Alumier Labs	87747f82-9018-ab34-e053-2995a90a6808	2024-12-01	Warnings	Exact identifier application number: M006
Acne Control Face Wash	SALICYLIC ACID	Bentley Laboratories, LLC	068c5fef-cdc5-49f4-9372-9cfdd07508b8	2024-11-28	Warnings	Exact identifier application number: M006
Acne Control Body Wash	SALICYLIC ACID	Bentley Laboratories, LLC	3db0f885-4c08-4678-8533-ba2025bf7d48	2024-11-28	Warnings	Exact identifier application number: M006
Neutrogena Stubborn Blackheads Daily Serum	SALICYLIC ACID	Kenvue Brands LLC	c0992ceb-5f7a-4c8f-a43f-7a300bd6bbf1	2024-11-26	Warnings	Exact identifier application number: M006
Neutrogena Stubborn Acne Spot Drying	SULFUR	Kenvue Brands LLC	dffe9bf4-a8a2-4fa0-e053-2995a90abcb3	2024-11-26	Warnings	Exact identifier application number: M006

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2191891	{1 (47 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (148 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	GPCK	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
106309	benzoyl peroxide 5 % Topical Lotion	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	Clenziderm Lotion 5 % Topical Lotion	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	CLENZIderm M.D. 2 % Medicated Liquid Soap	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	CLENZIderm M.D. 2 % Pore Therapy Topical Solution	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Medicated Liquid Soap	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
251577	salicylic acid 2 % Topical Solution	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
2191891	salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack	PSN	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion]	SBD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm]	SBD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	SBD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
106309	benzoyl peroxide 50 MG/ML Topical Lotion	SCD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 20 MG/ML Medicated Liquid Soap	SCD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
251577	salicylic acid 20 MG/ML Topical Solution	SCD	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
106309	benzoyl peroxide 5 % Topical Lotion	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	Clenziderm 20 MG/ML Medicated Liquid Soap	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	Clenziderm 20 MG/ML Topical Solution	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	Clenziderm Lotion 5 % Topical Lotion	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1236624	Clenziderm Lotion 50 MG/ML Topical Lotion	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235205	Clenziderm M.D. 2 % Daily Care Cleanser	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
1235208	Clenziderm M.D. 2 % Pore Therapy	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Facial Cleanser Toner	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Facial Scrub	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
562600	salicylic acid 2 % Medicated Liquid Soap	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
251577	salicylic acid 2 % Topical Solution	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3
2191891	salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack	SY	7710e51a-dd3a-4f44-8c97-c089c6817cb0	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
62032-610-11	62032061011	118 mL in 1 BOTTLE, PLASTIC	118 ml					Historical
62032-611-01	62032061101	47 mL in 1 BOTTLE, PLASTIC	47 ml					Historical
62032-612-04	62032061204	148 mL in 1 BOTTLE, PLASTIC	148 ml					Historical
62032-613-01	62032061301	1 KIT in 1 CARTON (62032-613-01) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-04)	1 kit	2012-01-01	0000-00-00	No	No	Current
62032-613-09	62032061309	1 KIT in 1 CARTON (62032-613-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11)	1 kit	2021-11-01	0000-00-00	No	No	Current
62032-613-15	62032061315	1 BAG in 1 CARTON (62032-613-15) > 1 KIT in 1 BAG * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11)	1 bag	2012-11-01	2022-12-31	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC	2025-03-19	HUMAN OTC DRUG LABEL	3